INM Stock Price Chart
INM Stock Price Prediction
InMed Pharmaceuticals Inc
$1.56
-1.88%
$-0.03
At close: Jul 02, 16:00:00 GMT-4
$1.49
-4.04%
$-0.06
Post-market: Jul 02, 20:00:00 GMT-4
Back
InMed Pharmaceuticals Inc (INM) Stock Price Prediction
Key Stats
Prev.Close
$1.59
Open
$1.6
Day's Range
$1.49 - $1.6
52 week range
$0.575 - $5.5
Volume
33.0K
Avg.Volume
1.1M
Dividend yield
--
EPS (TTM)
-2.88
Market Cap
$4.9M
What is INM?
InMed Pharmaceuticals, Inc. engages in developing small molecule drug candidates targeting the CB1/CB2 receptors. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-06-21. The firm develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.
